National Bank of Canada’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Sell |
15,081
-692
| -4% | -$11.6K | ﹤0.01% | 1262 |
|
|
2025
Q1 | $242K | Sell |
15,773
-1,003,753
| -98% | -$15.4M | ﹤0.01% | 1217 |
|
|
2024
Q4 | $22.5M | Buy |
1,019,526
+1,001,230
| +5,472% | +$22.1M | 0.02% | 409 |
|
|
2024
Q3 | $330K | Sell |
18,296
-1,259
| -6% | -$22.7K | ﹤0.01% | 1123 |
|
|
2024
Q2 | $319K | Sell |
19,555
-363
| -2% | -$5.92K | ﹤0.01% | 1123 |
|
|
2024
Q1 | $324K | Sell |
19,918
-16,483
| -45% | -$268K | ﹤0.01% | 1157 |
|
|
2023
Q4 | $388K | Buy |
36,401
+615
| +2% | +$6.56K | ﹤0.01% | 1159 |
|
|
2023
Q3 | $356K | Sell |
35,786
-18,225
| -34% | -$181K | ﹤0.01% | 1201 |
|
|
2023
Q2 | $406K | Buy |
54,011
+16,865
| +45% | +$127K | ﹤0.01% | 1194 |
|
|
2023
Q1 | $329K | Sell |
37,146
-31,521
| -46% | -$279K | ﹤0.01% | 1187 |
|
|
2022
Q4 | $626K | Sell |
68,667
-33,531
| -33% | -$306K | ﹤0.01% | 1096 |
|
|
2022
Q3 | $815K | Sell |
102,198
-1,907,924
| -95% | -$15.2M | ﹤0.01% | 913 |
|
|
2022
Q2 | $15.1M | Buy |
2,010,122
+1,900,596
| +1,735% | +$14.3M | 0.07% | 242 |
|
|
2022
Q1 | $1.03M | Buy |
109,526
+1,392
| +1% | +$13K | ﹤0.01% | 929 |
|
|
2021
Q4 | $834K | Buy |
+108,134
| New | +$834K | ﹤0.01% | 957 |
|